openPR Logo
Press release

In-Depth Examination of Segments, Industry Developments, and Key Players in the Artificial Intelligence (AI) in Clinical Trials Market

05-06-2026 03:08 PM CET | IT, New Media & Software

Press release from: The Business Research Company

Artificial Intelligence (AI) In Clinical Trials Market

Artificial Intelligence (AI) In Clinical Trials Market

The integration of artificial intelligence (AI) in clinical trials is transforming the landscape of medical research, promising faster, more efficient, and cost-effective trial processes. With increasing adoption and technological advancements, the AI in clinical trials market is poised for remarkable expansion. Below, we explore the market's valuation prospects, key players, emerging trends, and segment-wise insights shaping its future.

Projected Market Value and Growth Trajectory of the AI in Clinical Trials Market
The AI in clinical trials market is forecasted to experience significant growth, reaching a valuation of $47.22 billion by 2030. This surge corresponds to a robust compound annual growth rate (CAGR) of 35.3%. Factors driving this expansion include the rise of decentralized clinical trials, greater regulatory acceptance of AI technologies, advancements in precision medicine research, increasing demand for cost-effective trial methodologies, and improvements in healthcare analytics. Among the prominent trends expected to influence the market are AI-powered trial design optimization, predictive patient enrollment modeling, data-driven site selection, automated clinical outcome analysis, and adaptive trial execution platforms.

Download a free sample of the artificial intelligence (ai) in clinical trials market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12603&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=May_PR

Top Companies Dominating the AI in Clinical Trials Market
The AI in clinical trials sector features a wide range of influential companies leading innovation and market penetration. Some of the key players include Medable Inc., PathAI Inc., Saama Technologies Inc., TriNetX LLC, SymphonyAI Summit Inc., Aktana, Nference Inc., Insilico Medicine Inc., Vineti Inc., Innoplexus AG, Healx, AiCure Inc., MEDIAN Technologies SA, Owkin Inc., Science 37, Ardigen SA, Cyft Inc., Unlearn.AI Inc., Mendel AI, Deep Lens Inc., Antidote Technologies Inc., Arterys Inc., Euretos BV, Halo Health Systems Inc., Trials.AI Inc., Transparency Life Sciences, BioAge Labs Inc., Wave Life Sciences Ltd., and BioSymetrics Inc.

In a notable development in January 2023, US-based Paradigm Health Inc. acquired Deep Lens Inc. for an undisclosed sum. This strategic move equips Paradigm with Deep Lens's AI-driven cloud platform designed to broaden patient access to clinical trials, enhance trial efficiency, and lower participation barriers for healthcare providers. Deep Lens Inc. specializes in providing AI-powered solutions tailored for clinical research.

View the full artificial intelligence (ai) in clinical trials market report:
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-clinical-trials-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=May_PR

Emerging Innovations and Trends in AI for Clinical Trials
Companies within the AI in clinical trials market are increasingly investing in cutting-edge technologies such as AI feasibility and recruitment platforms. These platforms utilize AI to evaluate clinical trial viability and facilitate the efficient recruitment of suitable participants. For example, in June 2023, a US-based research firm launched 'ObjectiveScreen,' an AI-driven feasibility and recruitment tool aimed at improving clinical trial outcomes. ObjectiveScreen enhances patient identification, prequalification, and retention by directly linking clinical trial sites with patients' electronic health records (EHRs). This AI system also supports patient engagement by streamlining scheduling and communication, making the trial process smoother and more patient-friendly.

Detailed Segment Analysis of the AI in Clinical Trials Market
This market can be divided into several important categories that highlight its complexity and scope:
1) By Offering: Software and Services
2) By Process: Trial Design, Patient Selection, Site Selection, Patient Monitoring
3) By Application: Oncology, Neurological Diseases and Conditions, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, Immunology Diseases, and Other Applications
4) By End-User: Pharmaceutical and Biotechnology Companies, Contract Research Organizations, and Other End-Users

Further breakdown within these segments includes:
- Software types such as AI-driven analytics platforms, data management tools, patient recruitment solutions, and predictive modeling software
- Services such as consulting, data annotation and labeling, custom AI model development, and implementation and integration services

These segments reflect the diverse applications and service models driving the AI in clinical trials market forward, offering tailored solutions to various stakeholders within the clinical research ecosystem.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release In-Depth Examination of Segments, Industry Developments, and Key Players in the Artificial Intelligence (AI) in Clinical Trials Market here

News-ID: 4503565 • Views:

More Releases from The Business Research Company

Leading Companies Enhancing Their Presence in the Artificial Intelligence (AI) Robots Market
Leading Companies Enhancing Their Presence in the Artificial Intelligence (AI) R …
The artificial intelligence (AI) robots industry is poised for significant expansion as it integrates advanced technologies and broadens its applications across various sectors. This growth is driven by continuous innovation in robotics and AI capabilities, transforming how robots assist in both industrial and service environments. Let's explore the market size projections, key players, emerging trends, and segment breakdowns shaping this dynamic field. Projected Expansion of the Artificial Intelligence Robots Market The AI
Top Players and Competitive Dynamics in the Artificial Intelligence (AI) in Video Games Market
Top Players and Competitive Dynamics in the Artificial Intelligence (AI) in Vide …
The role of artificial intelligence (AI) in video games is rapidly evolving, driving significant growth and innovation within the industry. With new technologies reshaping gameplay and development processes, the AI in video games market is set to expand substantially in the coming years. Let's explore the current market size, leading companies, emerging trends, and key segments shaping this dynamic landscape. Projected Expansion of the Artificial Intelligence in Video Games Market The market
Worldwide Trends Review: The Rapid Development of the Artificial Intelligence (AI) in IoT Market
Worldwide Trends Review: The Rapid Development of the Artificial Intelligence (A …
The fusion of artificial intelligence (AI) with the Internet of Things (IoT) is creating remarkable growth opportunities and transforming how devices communicate and operate intelligently. This emerging market is advancing rapidly, driven by technological innovations and expanding applications across various industries. Let's explore the current market outlook, key players, influential trends, and segmentation details in the AI in IoT space. Anticipated Market Size and Growth Trajectory for AI in IoT The AI
Analysis of Key Market Segments Influencing the Artificial Intelligence (AI) Image Recognition Market
Analysis of Key Market Segments Influencing the Artificial Intelligence (AI) Ima …
The artificial intelligence (AI) image recognition sector is poised for significant expansion as technological advancements continue to reshape various industries. With increasing integration across multiple applications and sectors, this market is set to witness robust growth, driven by innovation and rising demand for intelligent image processing solutions. Let's explore the market's size, key players, emerging trends, and segmental insights to understand its trajectory better. Projected Market Value and Growth Rate of

All 5 Releases


More Releases for Trial

Clinical Trial Investigative Site Network Market Clinical Trial Investigative Si …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Clinical Trial Investigative Site Network Market - (By Therapeutic Areas (Oncology, Cardiology, CNS, Pain Management, Endocrine, Others), By Phase (Phase I, Phase II, Phase III, Phase IV), By End-use (Sponsor, CRO)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034." According to the latest research by InsightAce Analytic, the Global Clinical Trial Investigative Site Network Market
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025? The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025? The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with
Clinical Trial Management System
According to a new market report published by Persistence Market Research “Global Market Study on Clinical Trial Management System: Asia to Witness Highest Growth by 2019” the global clinical trial management system market was valued at USD 844.0 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of USD 1,848.5 million in 2019. Request Report TOC @ https://www.persistencemarketresearch.com/methodology/3017
Clinical Trial Logistics
Clinical Trial Logistics 16th to 17th May 2011, Marriott Regents Park, London, United Kingdom. It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical trials
Clinical Trial Logistics
Announcing SMi's 5th annual… Clinical Trial Logistics conference 16th and 17th May 2011, Central London, UK www.smi-online.co.uk/2011logistics-london6.asp It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical